MK

Mohandas Kamath Nileshwar

Director DIN 02942933
DIN 02942933 First appointment Mar 2010
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohandas Kamath Nileshwar

Data last updated:

Mohandas Kamath Nileshwar was a Director at Tajucco Pharma Private Limited (from 2010) and Whole-Time Director at Manipal Pharma Private Limited (from 2010).

DIN 02942933
First Appointment 17 Mar 2010
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tajucco Pharma Private Limited U85190KA2010PTC052930
Director16 Apr 20102010₹40.4 Lakh (FY 2019)Strike Off
Manipal Pharma Private Limited U85100KA2010PTC052866
Whole-Time Director17 Mar 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Tajucco Pharma Private Limited
Manipal Pharma Private Limited
Premium access

Shareholding and investment profile for Mohandas Kamath Nileshwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohandas Kamath Nileshwar

Mohandas Kamath Nileshwar was first appointed on 17 Mar 2010 as Whole-Time Director at Manipal Pharma Private Limited.

Mohandas Kamath Nileshwar held 2 earlier board appointments: Tajucco Pharma Private Limited (Director, from 16 Apr 2010); Manipal Pharma Private Limited (Whole-Time Director, from 17 Mar 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available